Insider · CIK 0001254452

Ross Michael Jay

Reports to the SEC for 8 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001254452

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-08	TRex Bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2022-06-15	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.2K sh	—	—	13,200
2021-10-21	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+26.4K sh	—	—	26,400
2019-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+79.5K sh	—	—	79,467
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+641K sh	—	—	720,907
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+202K sh	—	—	923,022
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+758 sh	—	—	758
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+6,128 sh	—	—	6,886
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+1,931 sh	—	—	8,817
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+341K sh	—	—	341,030
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+271K sh	—	—	611,720
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+252K sh	—	—	863,503
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+7,207 sh	—	—	7,207
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+5,721 sh	—	—	12,928
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+5,320 sh	—	—	18,248
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series E Preferred StockC Conversion	Director, 10% Owner	CConversion	−193K sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+943 sh	—	—	943
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+7,610 sh	—	—	8,553
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	Director, 10% Owner	CConversion	+2,399 sh	—	—	10,952
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−52.2K sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−9.22M sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series D Preferred StockC Conversion	Director, 10% Owner	CConversion	−6.68M sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series E Preferred StockC Conversion	Director, 10% Owner	CConversion	−9.16M sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−195K sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series D Preferred StockC Conversion	Director, 10% Owner	CConversion	−141K sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−21.8K sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−132K sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−64.8K sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.84M sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−11.1M sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−5.46M sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−17.5K sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−106K sh	—	—	0
2018-09-27	STROSUTRO BIOPHARMA, INC. · Series C Preferred Stock Warrant (right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−6,183 sh	—	—	5,361
2018-09-27	STROSUTRO BIOPHARMA, INC. · Series C Preferred StockM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+6,183 sh	—	—	64,815
2018-09-27	STROSUTRO BIOPHARMA, INC. · Series C Preferred Stock Warrant (right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−521K sh	—	—	451,869
2018-09-27	STROSUTRO BIOPHARMA, INC. · Series C Preferred StockM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+521K sh	—	—	5,462,550
2018-09-27	STROSUTRO BIOPHARMA, INC. · Series C Preferred Stock Warrant (right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−4,978 sh	—	—	4,315
2018-09-27	STROSUTRO BIOPHARMA, INC. · Series C Preferred StockM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+4,978 sh	—	—	52,183
2018-09-26	STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy Common Stock)A Award	Director, 10% Owner	AAward	+26K sh	—	—	26,033
2018-06-07	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2018-06-05	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-05-23	IVERIC bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2018-05-17	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2017-11-20	XFORX4 Pharmaceuticals, IncC Conversion	Director	CConversion	+322K sh	—	—	593,863
2017-11-20	XFORX4 Pharmaceuticals, IncP Purchase	Director	PPurchase	+483K sh	$10.00	+$4.83M	1,852,409
2017-11-20	XFORX4 Pharmaceuticals, IncP Purchase	Director	PPurchase	+16.6K sh	$10.00	+$166K	1,868,961
2017-11-20	XFORX4 Pharmaceuticals, Inc · Series A-1 Convertible Preferred StockC Conversion	Director	CConversion	−65.3K sh	—	—	0
2017-11-20	XFORX4 Pharmaceuticals, Inc · Series A-1 Convertible Preferred StockC Conversion	Director	CConversion	−1,380 sh	—	—	0

Recent filings

Accepted (ET)
Oct 8 21:524
Ross Michael Jay0001193125-26-418296
SEC(opens sec.gov)
Jun 174
Ross Michael Jay0001415889-22-006746
SEC(opens sec.gov)
Oct 254
Ross Michael Jay0001104659-21-129571
SEC(opens sec.gov)
Jun 134
Ross Michael Jay0001209191-19-036926
SEC(opens sec.gov)
Oct 14
Ross Michael Jay0001209191-18-052848
SEC(opens sec.gov)

Companies

Address

C/O TREX BIO, INC. 269 EAST GRAND AVENUE, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080